MLH1 and cancer: Along with the protein depletion confirmed by the immunochemistry assay, we confirmed the loss of expression of MLH1 at the RNA level, as well as the upregulation of EPCAM and TFF3 in tumor cells, which are known to be overexpressed in cancer cells [21, 22] (see Additional file 1: Figure S1).